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ABSTRACT:

Previous studies suggest that mature pancreatic acinar cells can transdifferentiate into duct and islet cells in vitro; however, the intrinsic factors
regulating this process have not been defined. The acinar specific transcription
factor MIST1 is required for acinar cell maturation and targeted deletion of M isti
(Mist1'A) in mice results in incomplete maturation of acinar cells, and increased
susceptibility to pancreatic injury. Previous studies revealed that the majority of
Mist1'A acini assumed a tubular complex phenotype when grown in culture. I
hypothesized that Mist1~A acini undergo trans-differentiation to duct cells in vitro
as well as in vivo after induction of cerulein induced pancreatitis. In mouse
primary acinar cell cultures, the temporal expression pattern of markers for
progenitor cells (PDX1), acinar cells (amylase) and duct cells (CK20) from days
1-11 of culture was examined. Immunofluorescence was performed on cryosectioned cultures. Acute pancreatitis was achieved by 7 hourly injections of
cerulein (50 pg/kg) and mice were sacrificed 24 h, 48 h, 72 h or 7days later and
compared to saline controls. Analysis of the tubular complexes just after
formation revealed expression of amylase, demonstrating an acinar cell origin.
Mist1'A but not wild type cultures also expressed PDX. By day 7, co-labelling
revealed MistTA tubular complexes containing CK20+/amylase+ and PDX1 +
cells. To definitively show the originating cell type for the tubular complexes
formed in Mist1'A cultures are acinar in origin, molecular lineage tracing analysis
was performed in which the R26R LacZ gene was permanently activated in

acinar cells. The outcomes demonstrate that deletion of MIST1 enhances the
trans-differentiation of acinar cells to other pancreatic cell types, such as duct
cells.

KEYWORDS: acinar cell, MIST1, trans-differentiation, de-differentiation, PDX1,
pancreatitis, lineage tracing
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CHAPTER 1:

INTRODUCTION

The pancreas consists of two separate compartments- the exocrine and the
endocrine compartments. The exocrine duct and acinar cells function to produce,
release and store enzymes for digestion, while the endocrine islet cells regulate
blood glucose levels (Slack, 1995). These two compartments are linked as they
share a common environment and are derived from a common progenitor
population during development. Proper differentiation, maturation, and
maintenance of these compartments are regulated by numerous cellular
interactions, signalling pathways, and transcriptional regulatory networks, and are
important for meeting an organism's metabolic needs. Re-activation of
developmental pathways, which occurs in response to injury, also increases
susceptibility to diseases such as pancreatitis and pancreatic adenocarcinoma
(Bardeesy et al., 2002).

Trans-differentiation, also known as adult cell reprogramming, is the conversion
or reprogramming of a committed, differentiated cell into another differentiated
cell type (Lardón and Bouwens, 2005). Trans-differentiation has been
documented in a number of cell types such as adipocytes (Barbatelli et al., 2010;
Okura et al., 2009), oocyte (Uhlenhaut et al., 2009) and myocyte (Bukovsky,
2009; Speer et al., 2009). However, trans-differentiation remains a controversial
topic among scientists. The objective of this thesis is to demonstrate how the
absence of the transcription factor MIST1 affects the terminal differentiation

status of pancreatic acinar cells, and results in the trans-differentiation of acinarduct cells in vitro as well as in vivo following injury.

1.1

The Pancreas

The pancreas consists of exocrine and the endocrine compartments (Puri and
Hebrook, 2010; Slack, 1995). The endocrine compartment consists of the islets of
Langerhans, which are comprised of cells that secrete glucagon (a), insulin (ft),
somatostatin (5), ghrelin (e), and pancreatic polypeptide (PP) (Puri and Hebrook,
2010; Prado et al., 2004; Murtaugh and Melton, 2003) (see Figure 1). (3 cells are
centrally located within the islet, while a, 5, and PP cells are located at the
periphery of the islet (Murtaugh and Melton, 2003; Prado et al., 2004). Insulin
producing (3 cells and glucagon producing a cells are the most abundant
endocrine cells type, with (3 cells comprising more than 75% of the islet (Prado et
al., 2004). Insulin and glucagon are secreted into the blood stream to aid in
glucose regulation, with insulin lowering blood glucose levels, while glucagon
raises blood glucose level (Puri and Hebrook, 2010; Kim & Hebrok, 2001; Slack,
1995). Ghrelin, is produced mainly in the stomach, but also within e cells, and
functions to increase secretion of growth hormone and also regulates food intake
and energy balance (Prado et al., 2004). Somatostatin and pancreatic
polypeptide regulate the secretion of other hormones and enzymes (Csaba and
Dournaud, 2001; Roncoronie et al., 1983).
2

The exocrine compartment, which comprises more than 95% of the pancreas, is
made up of a network of duct cells as well as acinar cells, which produce and
deliver digestive enzymes to the small intestine (Motta et al., 1997; Slack, 1995).
Acinar cells are polarized cells with a pyramidal shape and are organized into
clusters called acini. Acinar cells produce digestive enzymes, including
carboxypeptidase, trypsin, and elastase and store them as zymogens, or inactive
enzyme precursors, in the cytosol. Amylase, another digestive enzyme produced
by the pancreas is stored within the zymogen granules (Jura et al., 2005;
Murtaugh and Melton, 2003; Motta et al., 1997). These enzymes are secreted by
acinar cells into intercalated ducts that anastomose to form a series of
progressively larger inter and intralobular ducts before entering the common
pancreatic duct and finally into the duodenum to aid with digestion (Murtaugh and
Melton, 2003; Motta et al., 1997). The differential determination, development
and maturation of the aforementioned cell types occur due to the activation of
specific transcription factors during pancreatic development.

3
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Figure 1.1.

Pancreatic Cell Differentiation.

The exocrine, endocrine and duct portions of the pancreas are
derived from a common endoderm progenitor cell. Exocrine and
endocrine precursors are derived from a progenitor that expresses
pancreatic transcription factor 1, p48 subunit (PTF1a) and
pancreatic and duodenal homeobox 1 (PDX1). Transcription factors
are highlighted in blue and differentiation markers are highlighted in
red. Abréviations: cytokeratin 19/20 (CK19/20); glucagon (Glu);
insulin (Ins); somatostatin (SS); ghrelin (Ghr); pancreatic
polypeptide (PP); amylase (Amy); carboxypeptidase A (CPA).

PDX1+
PTF1a+

Common Pancreatic Progenitor cell

PDX1PDX1-

PTF1a

PTF1a+

Amy, CPA

^ ,u>lns>SS, ®hr>pp

5

1.2 Pancreatic Development

The murine pancreas originates as dorsal and ventral buds that form from the
primitive gut endoderm beginning at embryonic day (E) 9.5 from the distal end of
the duodenum (Motta et al., 1997; Slack 1995). Signaling from the notochord
initiates the formation of these pancreatic buds (Kim et al., 1997). The pancreatic
buds then come into contact and fuse as the stomach and duodenum rotate
(Sorensen et al., 2007; Kim & Hebrok, 2001; Slack, 1995) which occurs around
E12.5. These buds contain the precursor cells for islets, acini and ducts (Kim &
MacDonald, 2002). However, even before the formation of the pancreatic buds,
some cells of the primitive gut endoderm are already committed to a pancreatic
cell fate as determined by in vitro explant cultures (Wessells and Cohen, 1967).
This occurs as a result of growth promoting factors produced and secreted by the
mesenchyme (Golosow & Grobstein, 1962), such as fibroblast growth factors
(FGFs), bone morphogenic proteins (BMPs), activin and retinoic acid (RA)
(Dessimoz et al., 2006; Kumar et al., 2003).

Prior to E10, all cells destined to form the pancreas have the potential to become
any pancreatic cell, both exocrine and endocrine. Between E10.5 and E12.5,
cells can give rise to either the endocrine or the exocrine cell types (Gu et al.,
2003; Fishman and Melton, 2002). However, after E12.5 there is a clear
delineation between cells that are able to assume an endocrine versus an
6

exocrine cell fate (Gu, et al., 2002; Gittes & Rutter, 1992). This conclusion was
made from lineage tracing analysis using the Cre-ER™-LoxP system to mark the
progeny of cells expressing either Ngn3 or Pdx1 at different stages of
development (Gu, et al., 2002).

In the murine foregut, somatostatin (5 cells) mRNA is detected as early as E8.5
(Gittes & Rutter, 1992; Herrera et al., 1991). The other endocrine markers, insulin
((3 cells) and glucagon (a cells) are observed in the wall of the foregut in the area
of the duodenum from which the pancreas will arise 10-12 hours later at E9.5,
which is detected through mRNA expression and immunohistochemistry (Gittes &
Rutter, 1992; Herrera et al., 1991). Lastly, pancreatic polypeptide (y cells) mRNA
can be detected at E10.5, which is around the same time the dorsal pancreatic
bud becomes evident (Gittes & Rutter, 1992; Herrera et al., 1991).

Exocrine-specific markers such as carboxypeptidase (CPA) and amylase are
expressed at E10.5 and E12.5, respectively (Gittes & Rutter, 1992). Development
of exocrine cells into acini and ducts is recognizable by E14.5 (Kim & Hebrok,
2001; Slack, 1995), and further distinguished at E16.5 with the appearance of
zymogen granules (Bock et al., 1997; Gittes & Rutter, 1992). Expression of
exocrine markers later in development is crucial to prevent autolysis of the
exocrine tissue prior to the formation of zymogen granules (Gittes & Rutter,
1992).
7

1.3 Transcription Factors Involved in Pancreatic Development

Beginning in the 1990s, a series of important transcriptional regulators were
identified to play a role in pancreatic development. At embryonic day 9 (E9)
pancreatic progenitor cells express pancreatic and duodenal homeobox 1
(PDX1), which later becomes restricted to (3 cells of the endocrine pancreas, and
pancreatic transcription factor 1a (PTF1a), which later is restricted to acinar cells
of the exocrine pancreas (Kawaguchi et al., 2002; Macfarlane et al., 1999; Wu et
al., 1999; Debas, 1997).

1.3.1 Transcription Factors Expressed Early in Development

Pancreatic and duodenal homeobox 1 (PDX1), also called insulin promoter factor
1 (IPF1), and somatostatin transactivating factor-1 (STF-1), is a homeobox
transcription factor which marks pancreatic progenitor cells (Wescott et al., 2009;
Ohlsson et al., 1993). Expression of PDX1 is crucial for the proper development
of the pancreas, duodenum and endocrine cells of the stomach (Offield et al.,
1996; Larsson et al., 1996; Guz et al., 1995). PDX1 is initially expressed at E8.5
in endoderm cells of the dorsal foregut destined to form the pancreas and at E10

8

PDX1 is expressed in the dorsal and ventral pancreatic buds (Babu et al., 2008;
Hale et al., 2005). PDX1 expression is likely activated in the endoderm following
repression of Sonic Hedgehog and Indian Hedgehog signalling by fibroblast
growth factor 2 (FGF2) and activin I3 secreted by the notochord (Hart et al.,
2000 ).

All cells of the endocrine and exocrine pancreas are derived from PDX1 +
progenitor cells during embryogenesis (Gu et al., 2002). PDX1+ cells
transplanted under the kidney capsule differentiate into endocrine, acinar and
duct cells, further supporting the hypothesis that PDX1 is the earliest transcription
factor which can give rise to all three pancreatic cell lineages (Shiraki et al.,
2008). Deletion of the Pdx1 gene in mice results in neonatal mortality due to
hyperglycemia, as Pdx1~A mice fail to develop a pancreas (Jonsson et al, 1994).
Heterozygous mutations in Pdx1 impair glucose tolerance due to decreased 13cell mass and result in elevated blood glucose levels and insufficient insulin
production, two characteristics of diabetes (Babu et al., 2008).

Regulation of murine Pdx1 gene expression occurs through binding of the basic
helix-loop-helix (bHLH) protein upstream transcription factor 1 (USF-1) at the E
box, a consensus CANNTG promoter site that is the target for dimeric bHLH
proteins, as well as binding of the forkhead winged-helix transcription factor
hepatocyte nuclear factor 3(3 (HNF3&) at several sites which can open up
9

chromatin and provide access to other regulatory sequences (Sharma et al.,
1996). There are several sites on the Pdx1 promoter that are bound by HNF3G
(Marshak et al., 2000; Sharma et al., 1997; Wu et al., 1997). The PDX1 protein
itself binds to one of the HNF3(3 sites that contains a -TAAT- core sequence
suggesting that PDX1 autoregulates itself via a feedback mechanism (Marshak et
al., 2000).

Pancreatic transcription factor 1a (PTF1a), also called pancreatic transcription
factor 1, p48 subunit (PTF1-p48), is a bHLH pancreatic specific transcription
factor that is activated immediately following PDX1 and plays a role in acinar cell
maturation and differentiation (Krapp et al., 1998). PTF1a is expressed in
pancreatic progenitor cells and also in mature acinar cells where it regulates the
expression of acinar cell differentiation markers such as amylase, elastase 1,
chymotrypsinogen B, and carboxypeptidase (Habener et al., 2005; Krapp et al.,
1996). Ptf1a'A mice die shortly after birth and have no exocrine pancreatic tissue
(Krapp et al., 1998). While endocrine cells do develop, they migrate from the
intestinal mesentery and into the spleen (Krapp et al., 1998). PTF1a is involved in
the regulation of the Pdx1 gene as it binds to and activates the Pdx1 promoter,
thus suggesting it is involved within acinar and endocrine progenitor cells (Wiebe
et al., 2007).

10

1.3.2. Endocrine Specific Transcription Factors

Later in development, in the mature pancreas, PDX1 is primarily expressed in (3
and 6 cells of the islet of Langerhans, although its expression is also detected in
endocrine cells of the duodenum and developing brain (Perez-Villamil et al.,
1999). PDX1 inhibits cytokeratin (CK) 19/20 expression, which are both
expressed in mature duct cells suggesting that PDX1 negatively regulates duct
cell differentiation (Deramaudt et al., 2006). PDX1 is responsible for regulating a
number of (3 cell genes including insulin (Ohlsson et al., 1993), glucose
transporter 2 (GLUT2) (Waeber et al., 1996), glucokinase (Watanda et al., 1996),
islet amyloid polypeptide (IAPP) (Carty et al., 1997; Bretherton-Watt et al., 1996;
Serup et al., 1996), Paired Box gene 4 (Pax4), Nkx6.1, MafA (Babu et al., 2008)
and also regulates somatostatin gene expression in delta cells (Peers et al.,
1993). PDX1 binds to A-sites, TAAT motifs, within the upstream regulatory
regions of these genes and can also autoregulate its own expression (Marshak et
al., 2000). A number of other nutrients and hormones, such as insulin, can also
play a role in regulation of PDX1 (Macfarlane et al., 1994).

Neurogenin3 (NGN3), also called Math4B or Atoh5, is the first endocrine specific
transcription factor expressed during development (Gu et al., 2002) first detected
at E9-9.5 and peaking at E15.5 (Habener et al., 2005). NGN3 positive cells are
endocrine progenitor cells during development, as well as in adult mice, as
li

demonstrated through lineage tracing experiments by Gu et al., (2002).
Furthermore, Ngn3'A mice develop diabetes and die 1-3 days after birth due to
failure to develop pancreatic endocrine cells (Gradwohl et al., 1999). In these
mice, Isl1, Pax4, Pax6, and NeuroD, which are later endocrine markers, are not
expressed (Gradwohl et al., 1999). Over-expression of Ngn3 during
embryogenesis results in faster differentiation of endocrine progenitor cells
(Habener et al., 2005). NGN3 is not expressed in differentiated endocrine cells
(Schwitzgebel et al., 2000) and is a target of the Notch signalling pathway
(Wilson et al., 2003).

1.3.3 Exocrine Specific Transcription Factors

One of the first exocrine specific transcription factors is Hairy and Enhancer of
S plitl (HES1), which is controlled by Notch signalling and acts a negative
regulator of endocrine differentiation by inhibiting Ngn3 expression (Jensen et al.
2000). HES1 is essential for the maintenance of undifferentiated cells and when
HES1 is mis-expressed, acinar cell differentiation is inhibited (Kageyama et al.,
2000). Hes1'A mice display both premature neuronal differentiation as well as
defects in mature tissues of the brain, eye and pancreas (Kageyama et al., 2000)
Another transcription factor that regulates acinar cell differentiation is MIST 1
which is expressed in mature acinar cells.
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1.3.4 M ISTI

MIST1, also called BHLHA15, belongs to the class B family of bHLH proteins
(Lemercier et al., 1997) and is essential for normal pancreatic development.
MIST1 is a nuclear protein that binds to E-box DNA elements as a homodimer or
as a heterodimer with E-proteins E12 and E47 (Lemercier et al., 1997). However,
MIST1 preferentially forms homodimer complexes to activate gene transcription
(Jia et al., 2008). Interestingly MIST1 lacks a functional transcription activation
domain and may act as a regulator of gene expression (Lemercier et al., 1997)
and is necessary for complete differentiation and maturation of pancreatic acinar
cell phenotype (Pin et al., 2001).

M isti is initially expressed at E10.5, which is prior to the commitment of
pancreatic progenitor cell populations to the endocrine or exocrine cell fate (Pin
et al., 2001). However, later in development MIST1 is restricted to acinar cells,
and not expressed in centroacinar cells, duct cells, or islets based on
immunohistochemistry (IHC) data (Pin et al., 2001). MIST1 is also expressed in
all serous exocrine cells, such as salivary gland cells, lacrimal gland, and the
Chief cells of the stomach, each of which produce secretory products (Johnson et
al., 2004; Pin et al., 2000; Ramsey et al., 2007). MIST1 expressing cells depend
on regulated exocytosis for their proper functioning (Pin et al., 2000).

13

Deletion of the M isti gene (Mist1'A) results in disorganization and incomplete
maturation of mouse acinar cells (Pin et al., 2001). Furthermore, MistTA mice
exhibit intracellular zymogen activation and possess molecular changes observed
in pancreatic injury such as increases in transcription factors (p8), secreted
lectins (Regl/PSP and PAP1/Reglll) and the cholecystokinin A receptors (CCK
AR) (Pin et al., 2001) as well as disruption in calcium handling (Luo et al., 2005).
Therefore, MIST1 regulates genes controlling exocytosis, maintenance of cell
polarity and specifically within the pancreas, monitors normal acinar-ductal
homeostasis (Zhu et al., 2004).

By 5-months of age Mist1'A mice show decreased expression of (3-catenin, which
is a critical component of the adherens junction (Pin et al., 2001). Likewise,
MIST1 is a positive regulator of connexin32 (Cx32) gene expression as MistTA
mice show a decrease in Cx32 and consequently, a disruption in intercellular
communication pathways and acinar gap junctions (Rukstalis et al., 2003). As a
result of accumulated damage over time, MistTA mice develop lesions which
express duct and acinar markers, similar to the pancreatic damage seen in
pancreatic injury from disease (Pin et al., 2001). Additionally, exocrine pancreatic
defects that resulted from M isti deletion were rescued by ectopic expression of
MIST1 in acinar cells (Shi et al., 2009).

14

1.4 Trans-differentiation

Trans-differentiation, also known as adult cell reprogramming, or metaplasia, is
the conversion or reprogramming of a committed, differentiated cell into another
differentiated cell type (Lardon and Bouwens, 2005). Trans-differentiation has
been documented in a number of cell types such as adipocytes (Barbatelli et al.,
2010; Okura et al., 2009), ovarian follicles (Uhlenhaut et al., 2009) and muscle
cells (Bukovsky, 2009; Speer et al., 2009). Furthermore, acinar to liver trans
differentiation (Wu et al., 2010) and the pancreatic exocrine cell line AR42J can
trans-differentiate into hepatocytes and duct cells (Al-Adsani et al., 2010).
Recently, plant cells have been observed to also undergo trans-differentiation
(Yamaguchi et al., 2010; Abarca and Diaz-Sala, 2009). Likewise, trans
differentiation is observed both in the hydra Turritopsis nutricula in response to
environmental stressors (Carla et al., 2003) and the regeneration of the lens of
newts upon injury (Maki et al., 2010; Tsonis et a., 2004), demonstrating that this
process is not simply an in vitro phenomenon. Additionally, de-differentiation and
trans-differentiation likely arise in certain disease states, such as cancer or
pancreatitis (Jensen et al., 2005; Lechene et al., 1991).

Trans-differentiation goes against the once prevalent dogma that cells become
restricted to a particular cell lineage during development and that mature acinar
cells were terminally differentiated. It has been suggested that in vitro, acinar
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cells can revert back to a progenitor like cell, or un-differentiated intermediate,
through a process called de-differentiation. This “de-differentiated” intermediate
state often takes place before these cells continue on to become another
differentiated cell type (Bouwens, 1998).

1.4.1. Acinar cell trans-differentiation

Studies have demonstrated that acinar cells can trans-differentiate into other
terminally differentiated cell types in vitro including adipocytes (Bonal et al.,
2009), duct cells (Lardon et al., 2004; Zhu et al., 2004; Rooman et al., 2000;
Wagner et al., 1998), (3-cells (Sawey et al., 2007; Baeyens et al., 2005; Minami et
al., 2005; Sphyris et al., 2005; Song et al., 2004) and hépatocytes (Al-Adsani et
al., 2010; Wu et al., 2010; Lardon et al., 2004; Shen et al., 2000). Furthermore,
identification of a bi-potential progenitor, which has the ability to give rise to both
pancreatic cells and liver cells has been identified (Wandzioch and Zaret, 2009;
Chung et al., 2008; Deutsch et al., 2001). Liver to pancreatic cell trans
differentiation (Aviv et al., 2009; Wang et al., 2007; Kaneto et al., 2005; Ferber et
al., 2000), as well as pancreatic cell to liver cell trans-differentiation are both
documented (Grompe, 2003; Shen et al., 2000). However, to date, the molecular
events governing this process have only been partially elucidated.
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1.4.2 Trans-differentiation o f Pancreatic Cells During Injury and Disease

Tissue damage caused by pancreatic diseases, such as pancreatitis and
pancreatic adenocarcinoma, results in re-activation of developmental signalling
pathways. Along with a loss of differentiation markers, there is accumulation of
tubular complexes, or cyst like structures, which are characterized as cylindrical
tubes with a wide lumen and a monolayer of flattened duct like cells in their lining
(Jensen et al., 2005; Lechene et al., 1991). It is unclear if the origin of these
tubular complexes is the resident duct cells, a pancreatic stem cell population or
de-differentiated acinar cells (Wang et al., 1995). However, regardless of their
origin, there is a drastic shift in the cell make up of the pancreatic tissue from
acinar cells to these cyst-like structures (Hruban et al., 2001; Parsa et al., 1985),
and it has been suggested that they represent early cancer precursors (Bockman
et. al., 2003; Wagner et al., 1998).

Lineage tracing analysis has suggested that acinar cells are the cell type which
give rise to these tubular structures, and this is achieved through an
undifferentiated intermediate cell type which expresses the epithelial marker
nestin (Means et al., 2005), and pancreatic progenitor cell markers PDX1, Ecadherin, 0-catenin. Furthermore, re-activation of Notch signalling as evident by
expression of N otchl, Notch2, and Jagged2, and Notch target genes such as
Hes1 occurs during tubular complex formation (Jensen et al., 2005). Eventually,
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the forming cysts express ductal markers such as CK19 (Lardon et al., 2004; Vila
et al.,1994; Kim et al., 1990) and carbonic anhydrase II (Frazier et al.,1990),
markers of pancreatic duct cells. Interestingly, the degeneration of acinar tissue
and formation of tubular complexes following experimentally induced acute
pancreatitis is observed in several species, such as rats (Elsasser et al., 1986;
Odaira et al., 1986; Adler et al., 1979), mice (Jensen et al., 2005), dogs (Hureau
et al., 1966), rabbits (lovanna et al., 1988), and humans (Kloppel et al., 1986;
Adler et al.,1984; Bockman et al., 1983).

Activation of oncogenes, such as K-ras, deregulate the expression of tumor
suppressor genes, Cyclin-dependent kinase inhibitor 2A (CDK2A, also known as
p16INK4a)t protein 53 (p53), fragile histidine triad protein (FHIT) and mothers
against decapentaplegic homolog 4 (Smad4), also called deleted in pancreatic
cancer 4 (DPC4), which play a role in the initiation and progression of pancreatic
cancer (Koliopanos et al., 2008). Furthermore, upregulation of growth factors,
such as Transforming growth factors-(3 (TGF-(B), Epidermal growth factor (EGF),
Fibroblast growth factor (FGF) also occur in pancreatic cancer (Koliopanos et al.,
2008).

Mice that express the oncogene K-ras develop high-grade PanIN lesions and
PDAC after cerulein induced acute and chronic pancreatitis (Carriere et al., 2009;
Flabbe et al., 2008; Guerra et al., 2007). Low grade PanIN lesions stain positive
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for HES1 and PDX1, both markers of early progenitor cells, while high grade
PanIN lesions express ductal markers CK19 and Muc5a (Carriere et al., 2009;
Habbe et al., 2008; Guerra et al., 2007). Furthermore, pancreatic cancer cells co
express amylase (acinar) and CK19 (duct) markers within the same cell (Carriere
et al., 2009; Habbe et al., 2008; Guerra et al., 2007). However, stabilization of (3catenin signalling, which is required for acinar cell regeneration upon injury,
prevented the ability of Kras to promote this acinar-to-ductal trans-differentiation
(Morris et al., 2010).

Kras expressed from the M isti locus resulted in mice developing invasive and
metastatic pancreatic cancer, which was attributed to acinar cell de-differentiation
(Tuveson et al., 2006). M is tiKras/LacZ animals, lacking the MIST1 protein as a
consequence of expressed KrasG12D and (3-gal from the M isti locus, died three
days after birth (Shi et al., 2009). Furthermore, Shi et al., (2009) used
M isti LacZ/LacZ/LSL-KrasG12D/+/Ptf1aCre/+ mice with a constitutive active endogenous
KrasG12D allele and found these animals showed dramatic defects in their
exocrine pancreas and developed PanIN lesions at earlier stages than other mice
(Shi et al., 2009). Shi et al., (2009) also performed lineage tracing of LSLKrasG12DI+IMist1Cre'ERI+ mice and demonstrated what the PanIN lesions were
derived from KrasG12D expressing acinar cells. Interestingly, ectopic expression of
M isti in KrasG12DI+ acinar cells the deficits observed were rectified (Shi et al.,
2009). Shi et al., (2009) demonstrated this by crossing Mist1Krasl+ mice to
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Mist1LacZ/LacZ mice containing an elastase promoter-Mist1myc transgene (Elpr
Mist1myc) and showed that by expressing M isti from a different acinar-specific
promoter, Mist1Kras/LacZ mice were phenotypically identical to Mist1Krasl+ mice.
Lastly, in vitro analysis showed that acinar cells from these mice more readily
converted to a duct cell phenotype and activated EGFR and Notch signalling
pathways upon doing so (Shi et al., 2009).

1.4.3 Models used to study Pancreatic cell trans-differentiation

Primary cell culture experiments are important for understanding the normal
differentiation and physiological processes controlling cellular, tissue and organ
development. These experiments occur in a controlled environment where
scientists can methodically alter cell structure, activate/deactivate specific genes,
and alter culture conditions to understand normal cell biology as well as the
patho-physiologic processes of certain diseases (Ulrich et al., 2002). Cells can be
transduced with various genes hypothesized to be important in the normal
functioning or disease states, such as pancreatitis or pancreatic cancer (Ulrich et
al., 2002). Many, if not all of these processes are confounded or impossible to
perform initially in vivo to gain a thorough understanding of the mechanisms
involved. Furthermore, the acceptance that trans-differentiation occurs in certain
disease states, such as cancer, or pancreatitis is still very controversial.
Therefore, experiments which clearly outline which cell types are the founding
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population as well as the factors which promote or inhibit trans-differentiation is
critical, and this is an additional benefit and strength of primary cell culture
experiments.

Acinar cell trans-differentiation has been studied using primary cell cultures
where acinar cells are isolated from the rest of the pancreas and allowed to grow
over time. Trans-differentiation of acinar to duct cell (Sawey et al., 2007) or from
acinar to endocrine cell (Baeyens, Rooman and Bouwens, 2010; Baeyens et al.,
2009) has been observed, however, these studies have supplemented culture
medium with growth factors to force these pancreatic cell conversions to occur.
Isolated primary acinar cells have also been analysed using
immunocytochemistry, electron microscopy, western blotting and RT-PCR to
characterize the differentiation of these cells post-isolation (Larden and Bouwen,
2005; Larden et al., 2004). Unlike the present study, these studies did not use
lineage tracing which is required to definitively demonstrate the occurrence of
trans-differentiation.

Much of the initial work on acinar cell trans-differentiation was through the
assessment of cellular plasticity in acinar derived cell lines. AR42J cells were
obtained from a chemically induced carcinoma of the rat exocrine pancreas
(Jessop and Hay, 1980). These cells initially maintain acinar cell characteristics
such as amylase expression but can trans-differentiate into liver cells upon
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treatment with dexamethasone combined with Oncostatin M, a cytokine thought
to be important for liver development (Shen et al., 2000). Conversely, HepG2
cells, a human hepatoma cell line, can trans-differentiate into pancreatic cells
following transfection of Pdx1 (Li et al., 2005). Li et al., (2005) demonstrated
suppression of the hepatic phenotype during trans-differentiation of hepatocytes
to pancreatic cells and that PDX1 is not required once the pancreatic fate
program had been activated.

Careful consideration must be used when interpreting cell culture data however.
Cell-to-cell interaction is one of the most important cellular functions in an
organism, which is often disrupted in cell cultures (Ulrich et al., 2002). Similarly,
genetic manipulations of the cells can add additional concerns and can ultimately
alter some or many native functions and responses of the cells (Ulrich et al.,
2002). Additionally, the culture conditions primary cell cultures are placed in can
affect the shape, growth and survival of the cells in vitro. For instance, a study
done by Bendayan et al. (1986) found that primary acinar cells did not
morphologically look like acinar cells in vivo when plated on top of an
extracellular matrix, such as collagen, as they formed a monolayer of cells.
However, when these cells were embedded in a collagen matrix, the cells were
able to re-associate into acini in vitro, and consequently morphologically
resembled acinar cells in vivo.

22

In vivo injury models, such as pancreatitis have also been used to assess the
conversion of pancreatic acinar tissue into ductal tissue (Bockman, 1997). In
animal models of pancreatitis-induced injury, such as cerulein-induced
pancreatitis (Elsasser et al., 1986), ligation-obstruction of pancreatic ducts
(Rooman et al., 2002; Rooman et al., 2001; Wang et al., 1995), and after
pancreatectomy (Plachot and Portha, 2001), acinar to ductal trans-differentiation
has been observed.

1.5 Lineage Tracing

Understanding the precise lineage of cells is critical in order to understand the
developmental process of an organ system such as the pancreas. It is important
to be able to identify particular cell types as well as their descendants and several
methods have been developed to achieve this goal. The first attempt at studying
cell lineages was done in 1905 by Carl Otis Whitman, Edmund B. Wilson and
E.G. Conklin using pigments to study cleavages in embryos of invertebrates
(Stern and Fraser, 2001). Technological advancements, such as “four
dimensional time-lapse video microscopy,” allowed individual cells which had
been labeled with a dye to have its position recorded in real time in all three
dimensions and was used to trace the complete lineage of Caenorhabditis
elegans (Thomas et al., 1996; Sulston et al., 1983). However, one problem with
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this method is that a cell can migrate to a location where it is not being filmed, or
behind a structure, which is opaque (Thomas et al., 1996; Sulston et al., 1983).

Another approach used in lineage tracing analysis involves genetically marking
pancreatic cells with endogenous genes that are expressed at one point during
pancreatic development or in the mature pancreas. By selecting tissue specific
promoters, and using them to drive the expression of site specific DNA
recombinases, investigators can irreversibly label specific cell types, and the fate
of their progeny can be mapped (Herrera, 2000; Jasinski et al., 2001; Kisanuki et
al., 2001; Nagy and Mar., 2001). The development of site-specific recombinases
has been an important development for genetic analysis in mice.

One of these systems, the cre/lox site-specific recombinase was developed as a
tool for the generation of conditional somatic mouse mutations which can be
induced in almost any tissue of the mouse (Fiel 2009). Furthermore, development
of ligand-dependent ere recombinases, which are activated by administration of
tamoxifen to the animal, allow gene activity to be temporally controlled. Other
experiments have performed lineage tracing using Cre-recombinase
adenoviruses driven by the mouse amylase-2 promoter (Dematteo et al., 1997) or
rat elastase-1 promoter (Hammer et al., 1987), which were then used to infect
cultured acinar cells from ROSA26 (R26r) reporter mice (Minami et al., 2005). In
this model, Cre-recombinase removes the loxP stop codon and allows expression
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of enhanced cyan fluorescent protein (ECFP) only in mature acinar cells (Srinivas
et al., 2005).

In the pancreas, lineage-tracing analysis can be used to identify progenitor cells
that give rise to specific mature pancreatic cells (Gu et al., 2002). This in turn
allows scientists to study their growth, in vitro differentiation, and gene expression
of pancreatic progenitor cells and consequently allows for investigation of
extracellular signals and the genetic programs involved in pancreatic maturation
(Gu et al., 2002).

1.5.1 Cre-loxP System

Cre recombinase is a 38 kDa protein from the ere (cyclization recombination)
gene of the bacteriophage P1 (Sternberg, 1978) and is a site-specific DNA
recombinase of the integrase protein (Int) family (Argos et al., 1986). Cre
recognizes a 34-bp site on the P1 genome called loxP (locus of X-over of P1)
which are two inverted repeats of 13 bp palindromic sequences, separated by an
8 bp spacer (Hoess et al., 1984; Hoess et al., 1982). Cells can be irreversibly
marked using the Cre/LoxP system (Sanes, 1994; Sato et al., 2000), which
allows for detection of daughter cells which no longer express the gene of
interest. Each loxP site is bound by one Cre recombinase monomer and the DNA
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between the two loxP sites is excised through recombination resulting in
activation or inactivation of the gene in question (Sauer 1988).

More recently genetic lineage-tracing analysis has been developed in which the
fate of a single cell type can be assessed over time in vivo as well as in vitro.
Minami et al., (2005) used the Cre/loxP lineage tracing system to show that
approximately 5% of acinar cells can trans-differentiate in vitro into (3 cells after
isolation and treatment with Epidermal growth factor (EGF; a growth factor which
is important for cell growth, differentiation and proliferation) and nicotinamide.
These new (3 cells demonstrated similar properties to native pancreatic (3 cells,
such as insulin secretory granules, glucose sensing genes, regulated exocytosis,
and the ability to process proinsulin to mature insulin in response to glucose.
Similarly, Strobel et al., (2007) also took advantage of the Cre/loxP lineage
tracing analysis to show that some of the metaplastic lesions that arise in vivo
after CIP occur through acinar-to-duct trans-differentiation.

1.5.2 LacZ System

One histochemical reporter gene commonly used in lineage tracing is the LacZ
gene. The LacZ gene encodes (3-galactosidase which is an enzyme that cleaves
lactose to produce galactose and glucose in E. Coli from which the LacZ gene is
taken (Miesfeld 1999). (3-Galactosidase catalyzes the hydrolysis of X-Gal, (also
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known as BCIG or bromo-chloro-indolyl-galactopyranoside), which is an organic
compound made of galactose covalently bonded to a substituted indole (Joung,
Ramm and Pabo, 2000). X-gal is cleaved by (3-galactosidase yielding galactose
and 5-bromo-4-chloro-3-hydroxyindole which is detected by an insoluble
permanent blue precipitate (Joung, Ramm and Pabo, 2000). This product can
easily be detected under a microscope and thereby provides an ideal way to
detect LacZ expression within cells or tissues. To conditionally activate the LacZ
gene, a construct is created in which expression is under the control of the
Rosa26 promoter, which is constitutively active. The construct contains two loxP
sites flanking a TAA-STOP codon, which is removed upon Cre activity and is
maintained in descendents of this cell. In other words, (3-galactosidase is only
expressed following Cre-mediated recombination (Soriano, 1999).

1.5.3 Cre Reporter Mice

In the present study, I employed genetically altered mice with the M isti coding
region replaced with a modified cre recombinase protein, M is tiCreERT mice. The
cre recombinase protein was fused to an estrogen receptor, but was only
responsive to tamoxifen, a synthetic estrogen antagonist, rather than
endogenous estrogen (CreERT). This CreERT is expressed identically to M isti
but remains cytoplasmic and inactive until treatment with tamoxifen. As a readout
for cre activity, M is tiCreERT mice, were mated to ROSA26rloxPstoplacZ mice,
designated as R26r for brevity. When mice are exposed to tamoxifen, heat shock
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proteins dissociate from the CreERT allowing it to translocate to the nucleus and
cause recombination, removing the stop codon from the ROSA26-stop-LacZ
transgene which then allows for the permanent expression of B-galactosidase in
cells that express MIST 1 and all of their descendents (see Figure 1.2).

1.6

Signalling pathways involved in Trans-differentiation

Minami et al., (2005) showed that acinar to (3-cell trans-differentiation is
dependent on extracellular signal regulated kinases ERK1 and ERK2 signalling,
which are members of the Mitogen activated protein kinase (MAPK) family.
MAPKs are a family of serine/threonine specific protein kinases that
phosphorylate target proteins such as other protein kinases and transcription
factors (Johnson and Lapadat, 2002). MAPKs respond to extracellular stimuli, for
instance, inflammatory cytokines and growth factors, and also regulate a variety
of cellular activities, including differentiation, gene expression, mitosis, cellular
movement, metabolism, apoptosis and cell survival (Pearson et al., 2001; Malka
et al., 2000; Johnson et al., 1996; Gottschalk et al., 1994; Harrington et al., 1994;
Pages et al., 1993).
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Figure 1.2.

Genetic mouse model for following fate of mature

acinar cells.

M is ti+/CreERTROSA26r mice contain a targeted M isti locus that has
the M isti coding region replaced with CreERT. Therefore the
modified ere recombinase is expressed wherever MIST1 is
expressed. At the same time, these mice contain a ROSA26-stopLacZ reporter (R26r) gene. A translational stop codon is flanked by
loxP sites and, without recombination, no (3-galactosidase (3-gal) is
expressed. M is ti+/CreERTK0 or Mist1CreERTK0/CreERTK0 mice
homozygous for the Mist1CreERTlocus and therefore, a null animal
for M isti. In the absence of tamoxifen, pancreatic acnar cells
express Cre-ERT, which is localized to the cytoplasm through the
binding of heat shock proteins (hsp). Upon addition of tamoxifen,
hsp dissociates from CreERT, allowing the recombinase to
translocate to the nucleus, where it binds to the loxP sites and
causes a permanent genetic rearrangement that now allows for the
expression of 3-galactosidase, which would be maintained
independent of cell identity.
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There are several subfamilies of MAPKs: ERK 1, ERK2, two ERK3 isoforms,
ERK4, Jun N-terminal kinases/stress-activated protein kinases (JNK/SAPKs),
p38/HOG, and p57 MAP kinases. Of these subfamilies, extracellular signal
regulated kinases ERK1 and ERK2 are likely important for acinar-ductal trans
differentiation and insulin gene expression (Sawey et al., 2007; Means et al.,
2007; Minami et al., 2005; Khoo et al., 2003). When Minami et al., (2005)
inhibited ERK1/2 activity the trans-differentiation of acinar to 3-cells was greatly
reduced.
In addition to ERK signalling, several other signalling factors are implicated in
acinar-duct trans-differentiation. c-Myc conditional inactivation in PDX1 progenitor
cells resulted in acinar cells trans-differentiating into pancreatic adipose cells
(Bonal et al., 2008). The acinar cell line B-13 trans-differentiates into B-13
hepatocytes by transient repression of WNT signalling through direct
phosphorylation of 3-catenin by SGK1C, serine/threonine protein kinase 1C, in
response to elevated glucocorticoid levels (Al-Adsani et al., 2011; Wallace et al.,
2011; Wallace et al., 2010). Furthermore, treatment with the glucocorticoid
dexamethasone induced trans-differentiation of AR42J-B13 acinar cell line to
duct cells (Al-Adsani et al., 2011).

Matrix metalloproteinase 7 (MMP-7), another signalling factor identified, is
necessary and sufficient for Notch activation and subsequent de-differentiation of
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acinar cells to a nestin-positive transitional cell (Sawey, Johnson and Crawford,
2007). Pancreatic acinar to duct cell trans-differentiation occurs when acinar
cells are exposed to growth factor signalling, such as TGF- a (Blaine et al., 2010).
Young-Hye et al., (2011) employed adenoviruses to overexpress PDX1,
BETA2/NeuroD and MafA in porcine pancreatic cell clusters from post natal day 2
neonates, as well as adult porcine acinar and duct pancreatic cells. They
demonstrated that the neonatal cell clusters and adult acinar and duct cells could
be trans-differentiated into (3-cells.

1.7

Objectives and Hypothesis

Rationale:

The acinar-specific transcription factor MIST1 is required for acinar cell
maturation and targeted deletion of M isti (Mist1v~) in mice results in incomplete
maturation of acinar cells. Preliminary studies in our laboratory have revealed a
different response to the ex vivo environment between MistTA and wild type
acinar cells. The majority of MistTA acini assume a tubular complex, or cyst like
structures, which are characterized as cylindrical tubes with a wide lumen and a
monolayer of flattened duct like cells in their lining (Jensen et al., 2005; Lechene
etal., 1991), similar to what is observed in acinar to duct cell trans-differentiation
that occurs under certain experimental conditions and pancreatic disease (Figure
1.3, Peat et al., unpublished observations). However, the studies did not address
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the molecular mechanisms governing the establishment of these tubular
structures nor their specific cell origin.

Based on previous studies I hypothesize that Mist1v~acinar cells undergo trans
differentiation to duct cells, in vivo as well as in vitro which may involve a
progenitor intermediate cell fate.

To test this hypothesis I have two objectives:
1. Characterize the expression of proteins involved in pancreatic
differentiation in acinar cell cultures derived from wild type and Mist1'A
pancreatic tissue.

2. Determine if acinar cells are the cells of origin for tubular complex
formation.
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Figure 1.3:

Comparison o f WT and MistTA acini in culture. The

morphology of MistTA (A-C) and WT (D-F) cells was analyzed from
1 to 11 days in culture for the presence of tubular complexes
(arrow). Representative acinar cell clusters isolated from 4-month
animals demonstrated an increased propensity of Mist1'A acini to
develop these structures. Scale bar represents 50 pm. This figure
was prepared by Jodi Peat.

Mist1'A

WT
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CHAPTER 2:

2.1

MATERIALS AND METHODS

Mice

All experiments carried out on mice were in accordance with Animal Care and
Use at the University of Western Ontario, protocol #2008-116. All mice were fed a
standard diet and water ad libitum. C57BL6 mice were generated with the M isti
coding region replaced with the E. coli LacZ gene 7 bp upstream of the
translation start site for M isti as previously described (Pin et al., 2001).
Heterozygote (Mist1LacZ/+) mice were mated to wildtype (WT) and Mist1'A
(M is tiLacZ/LacZ] referred to as Mist1+/+), animals which resulted in fc-galactosidase
being expressed as M isti would normally be expressed (Pin et al., 2000). To
identify the genotype of each mouse, polymerase chain reaction (PCR) was
performed using the following primers:

M is tl forward primer (Sigma 205-11), 5’ GATCATGTCTGGACCTGTGTCA 3’
M istl reverse primer (Sigma 205-12), 5’ GGCTGCTGGACATAGTAAGTAT 3’
LacZ reverse primer (Sigma 205-13), 5’ CCTCTTCGCTATTACGCCAGCT 3’
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The amplicon produced from the endogenous M isti gene was 886 bp whereas
the amplicon produced from the presence of the LacZ gene was 705 bp. All
studies used female two to four month old animals unless otherwise stated.

Genetically altered mice with the M is ti coding region replaced with a modified ere
recombinase protein, Mist1+/CreERTmice were used in the lineage tracing
experiments. The ere recombinase protein has been fused to an estrogen
receptor, but is only responsive to tamoxifen, rather than endogenous estrogen
(CreERT). For lineage tracing studies homozygous Mist1CreERT/CreERTR26r and
heterozygous M is tiCreERT/+R26r mice were used. To genotype these mice the
following primers were used:

MCre (Sigma 80389-001), 5’ GAAGCATTTTCCAGGTATGCTCAG 3’
M C re l (Sigma 80389-002) 5’ GGTTTAAGCAAATTGTCAAGTACGG 3’
MCre 2 (Sigma 80389-003) 5’ ATAGTAAGTATGGTGGCGGTCAGCG 3’
LacZ 3 (Sigma 7484-023) 5’ CGTGGCCTGATTCATTCC 3’
LacZ 5 (Sigma 7484-024) 5’ ATCCTCTGCATGGTCAGGTC 3’
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The amplicon produced from the presence of the Mist1Cre'ERT gene was 750 bp
and the amplicon produced from the presence of the LacZ gene was 315 bp. All
experiments carried out on mice were in accordance with Animal Care and Use
at the University of Western Ontario, protocol # 2008-116.

2.2

Tamoxifen Injections:

Tamoxifen (Sigma-Aldrich, Saint Louis, MO) was re-suspended in 100% ethanol
(Commercial Alcohols, Toronto, ON) at a concentration of 50 mg/mL and warmed
at 37°C until completely dissolved. The tamoxifen-ethanol mixture was diluted in
corn oil at a concentration of 20 mg/mL, vortexed for 5 minutes and finally
sonicated for 1-2 minutes. This solution was stored at 4°C and warmed at 37°C
prior to, and during gavage treatment. Two to four month old male mice ranging
from 25-35 g were gavage treated with 4 mg of Tamoxifen every second day, for
eight days so that each mouse received a total of four tamoxifen injections. Mice
were allowed at least one week to recover from these injections before receiving
any further treatment.
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2.3

Cerulein Induced Pancreatitis (CIP)

At least one week after the last tamoxifen injection was administered, mild,
edematous, acute pancreatitis was induced in Mist1+/CreERTand M is tiCreERT/CreERT
male mice. Littermates were given seven hourly intraperitoneal injections of
caerulein (Sigma, 50 pg/kg body weight) or saline (as a control). Caerulein and
saline injected mice were sacrificed 24 hours (n=3), 48 hours (n=3), 72 hours
(n=3) and 7 days (n=3) after initial caerulein injection. Tissue was processed as
described in section 2.6.

2.4

Primary Acinar Cell Culture:

Primary cell cultures embedded in a 3D-collagen matrix were established from
pancreatic tissue of each mouse line. Pancreata were dissected and immediately
placed in a washing solution of Dulbecco’s Modified Eagle Medium (DMEM;
GibcoBRL, Burlington, ON), containing 1% Penicillin/1% Streptomycin (1%
PenStrep; GibcoBRL) and 0.1 mg/mL Soybean Trypsin Inhibitor (GibcoBRL),
which was oxygenated for 20 minutes. The pancreas was trimmed of fat and
injected with 5 mL of DMEM solution containing 200 pL of 1000 U/10 mL
collagenase (Sigma). The distended pancreas was cut into approximately 5-10
smaller pieces and incubated in the DMEM/collagenase solution for 10 minutes,
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oxygenated for one minute and incubated in an oscillating water bath at 37°C and
80 rpm. After the 10 minutes, the DMEM/collagenase solution was replaced with
fresh solution, oxygenated for one minute, and incubated again for a remaining
40 minutes.

Following incubation, the pancreatic tissue was dissociated by pipetting through
increasing smaller orfices. The resulting cell slurry was passed through a 150 mm
nylon mesh filter and into a 50 mL Falcon tube. The remaining tissue on the filter
was rinsed with 30 mL of 4% DMEM-bovine serum albumin (BSA; VWR,
Mississauga, ON) solution. The filtered solution, containing isolated cells was
divided evenly into 4 aliquots and centrifuged at 500 rpm for 3 min. The
supernatant was removed and cells were washed with another 4% DMEM-BSA.
The supernatant was removed and cells were combined into two tubes and
rinsed with 1% BSA and centrifuged again. Cells were then combined into one
tube, rinsed with 1% BSA and centrifuged for the last time at which point they are
ready to be cultured.

Cells were plated in a collagen matrix (1:1 mixture of DMEM containing 1%
PenStrep and type I Rat Tail Collagen (3.68 mg/mL; VWR)). The collagen was
vortexed and then added to the isolated cells after the supernatant was removed.
This mixture was vortexed again as Neutralization Buffer (2:3 ratio of 0.34 M
NaOH and 10x Waymouth Media; Sigma-Aldrich) was added in a drop wise
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fashion until the solution obtained a dark pink colour (about 40 pL per 6 mL of
mixture). 600 pL of the cell mixture was added to each well of a 6-well Corning
Culture Treated tissue culture plate. The collagen-cell mix was allowed to set in
the plate for 5 minutes and then 2 mL of Basal Media containing 1% PenStrep,
0.1 mM 3-isobutyl-1-methyl-xanthine (IBMX; Sigma), 1 pM dexamethasone
(Sigma) and 0.25 pg/mL Amphoteracin B (GibcoBRL) was added over the matrix
surface. Cultures were incubated at 37°C and 5% CO 2 and followed up to 11
days. Media was replaced every second day.

2.5

Preparation of Frozen Cell Culture Sections

At days 1, 3, 5, 7, 9 and 11 (n=3 per condition) cultures were fixed overnight in
4% formaldehyde at 4°C in phosphate buffered saline (PBS) followed by 3x5min
PBS washes. The supernatant was removed and the cell-collagen mixture was
then treated with 5%, 10% and 20% sucrose in PBS for 24 hours each. The cellcollagen mixture was embedded in Shandon Cryomatrix (Thermo Scientific,
Ottawa, ON) and sectioned to 6-8 pm using a Shandon Cryostat (Thermo
Scientific, Ottawa, ON) onto charged slides (Fisher Scientific, Rockford, IL) and
stored at -80°C.
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2.6

Preparation of Frozen Pancreatic Tissue Sections

Pancreatic tissue was dissected fresh from mice, embedded in Shandon
Cryomatrix (Thermo Scientific, Ottawa, ON), and stored at -20°C until processed.
Frozen tissue was sectioned to 6-8 pm using a Shandon Cryostat and mounted
onto charged slides and stored at -80°C until used.

2.7

Immunofluorescent Analysis

For immunofluorescent (IF) analysis, sections were allowed to dry at room
temperature before being fixed for 10 minutes with 4% formaldehyde. Sections
were then washed 3x5 minute with PBS and permeabilized with 0.1% Triton X100 for 10 minutes followed by another 3x5 minute wash with PBS and placed in
blocking solution (5% BSA in 0.1% Triton X-100 in PBS) for 30 minutes. Slides
were incubated for one hour in primary antibody diluted in blocking solution.
Primary antibodies used were rabbit antibodies specific for amylase (1:1000,
Calbiochem, San Diego, CA), PDX1 (1:2000, Abeam Inc., Cambridge, MA),
phospho histone H3 (1:200, Millipore, Temecula, CA), and Ki67 (1:1000,
AbCam), and mouse antibodies specific for CK20 (1:20, Dako, Mississauga, ON),
CK20 (1:50, Santa Cruz) and insulin (1:500, Sigma, Saint Louis, MO), o ra
chicken antibody specific for 3-galactosidase (3-gal; 1:500, AbCam).
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Following primary incubation, sections were washed 3 x 5 minutes with PBS and
then incubated with secondary antibodies diluted in blocking solution (1:250) for
one hour. Secondary antibodies (Sigma, Saint Louis, MO) used included
tetramethylrhodamine isothiocyanate (TRITC)- conjugated goat anti-rabbit IgG,
TRITC goat anti-mouse IgG, fluorescein isothiocyanate (FITC)-conjugated goat
anti-mouse, FITC goat anti-rabbit, and FITC-conjugated goat anti-chicken
(AbCam) and then washed for 3 x 5 minutes with PBS followed by a 5 minute
incubation in diamidino-2-phenylindole dihydrochloride hydrate (DAPI, 1:1000)
and mounted with Vectashield (Vector Laboratories, Burlington, ON). As a
negative control slides were prepared with no primary antibody. IF was visualized
using Olympus FluoViewlOOO coupled to the 1X81 Motorized Inverted System
Microscope (IX2 Series) or a Leica DMIOF upright microscope with images
captured using Openlab 3.1.5 (Quorum Technologies, Guelph, ON). Multiple
fields of view were photographed and the amount of PDX1+ nuclei per 100 DAPI
nuclei was counted. The percentage of PDX1 positive nuclei was determined as
a proportion of 100 DAPI stained nuclei present in tubular complexes as well
among individual cells.

2.8

X-gal Staining

Pancreatic sections from tamoxifen treated mice were fixed with 4%
formaldehyde in PBS for 8 minutes and then washed with PBS for 3x5 minutes.
43

Tissue was then incubated at 37°C with X-gal solution (4 mM potassium
ferricyanide, 4 mM potassium ferrocyanide, 2 mM MgC^and 0.1% X-gal (Thermo
Fisher Scientific, Rockford, IL) in PBS until blue staining became visible. Sections
were washed 3x5 minutes in PBS before haematoxylin and eosin staining was
performed. Counterstained sections were dehydrated and mounted using
permount (Fisher). Cell cultures were stained for X-gal as described above prior
to sectioning. After staining, cells were sucrose treated, sectioned and processed
as outlined in section 2.5.

2.9

TUNEL Labelling for Detection of Apoptosis

Two slides per treatment condition were brought to room temperature and then
fixed for one hour with 4% formaldehyde in PBS. After being rinsed 3 x 5 minutes
with PBS, samples were permeabilized with 0.1% Triton X-100 in 0.1% sodium
citrate for two minutes on ice, followed by 2 x 5 minute PBS washes. Sections
were incubated with terminal deoxynucléotidyl transferase dUTP nick end
labelling (TUNEL) reaction mixture (Roche Diagnostics, Laval, PQ) in the dark for
one hour at 37°C and washed 3 x 5 minutes with PBS followed by a DAPI
(1:1000) incubation for 5 minutes. Finally slides were rinsed again 2 x 5 minutes
with PBS and mounted using Vectashield. Slides were visualized and images
captured as described above for IF analysis. Positive and negative controls were
also used. Positive Controls were incubated with DNase I (3000U/ml in 50 mM
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Tris-HCI, pH 7.5, 1mg/ml BSA) for 10 minutes at 25°C to induce DNA strand
breaks, prior to labelling. Negative Controls were incubated with label solution
only (without terminal transferase) instead of TUNEL reaction mixture.

2.10 Statistical Analysis

Quantitative results are expressed as means ± Standard Error (SE). All statistical
analyses were performed using GraphPad Prism 4.02 for Windows (GraphPad
Software, San Diego, CA, USA). Significance was determined using two-way
ANOVAs with time and genotype as group variables and Bonferroni post hoc test.
Significance was considered p < 0.01.
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CHAPTER 3:

3.1
v itro

RESULTS

Pancreatic acinar cells lose their differentiated acinar phenotype in

Previous work in the lab has shown that Mist1'A mice develop tubular complexes
in vitro (Peat et al., 2008) as well as in vivo in response to pancreatic injury
whereas their WT counterparts do not (Kowalik et al., 2007). These tubular
complexes were hypothesized to be acinar cells that had de-differentiated into
duct-like cells. To determine if Mist1'A acinar cells undergo trans-differentiation
into duct cells, primary acinar cells were isolated from Mist1'A animals (n=3) and
embedded in a collagen matrix to allow for three dimensional growth similar to in
vivo. Acinar and duct cell markers were then assayed using co-IF labelling of
amylase (acinar) and cytokeratin 20 (duct).

Immediately upon culturing, both WT and Mist1'A acinar cell cultures express
amylase, but not CK20 (Figure 3.1; A-B; F-G). By day 5, cells positive for
amylase could be observed within the tubular complexes of Mist1'A cultures
(Figure 3.1 C, white arrow; *). Furthermore, accumulation of both amylase and
CK20 was observed within the same tubular complex (Figure 3.1, C; yellow
arrows; *). Additionally, CK20 expression increased in M is t T cultures, as an
accumulation of CK20 was seen within the tubular complexes at Day 7 (Figure
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Figure 3.1: The expression o f acinar cell markers is replaced over
time by duct cell markers in MistTA acinar cell cultures. Coimmunofluorescent (IF) analysis was

performed for

amylase

(acinar; red) and CK20 (duct; green) on sections of M is t T (A-E) or
wild type (WT; F-J) acini cultured for 1-9 days. By day 5 (C) tubular
complexes (*) were observed and expressed amylase (white
arrows). By day 7 (D) the tubular complexes were positive for CK20
(yellow arrows), which became more pronounced by day 9 (E).
Sections were counterstained with nuclear marker DAPI (blue).
Scale bar = 30 pm (n=3; 3 M is ti"A mice; 3 WT mice used for culture
D1-11).

M is ti'-

WT

D1
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3.1, D; yellow arrows; *). By Day 9, entire tubular complexes showed CK20
accumulation (Figure 3.1; E; yellow arrows; *). WT cultures, on the other hand,
showed minimal to no CK20 staining at these time points (Figure 3.1; H, I, J).

Part of the trans-differention process involves an initial de-differentiation step to
more progenitor-like cells, whereby cells show re-activation of markers seen in
the developing pancreas, such as PDX1. Therefore, Mist1'A cultures should
express progenitor cell markers, such as PDX1, during the initial de
differentiation step. MistTA cultures (n=3) expressed PDX1 over the first 7 days
in culture (Figure 3.2 (I); A-B), whereas WT cultures (n=3) did not (Figure 3.2 (I);
D-E). Very few cells expressed PDX1 in WT cultures, with no expression at Day 0
and Day 1, and 2.4±1.12% of cells expressing PDX1 at Day 7 (Figure 3.2 II).
Conversely, M i s t i cultures contained no PDX1 staining at Day 0, but 45.6±1.9%
PDX1 positive cells at Day 1, 68.9±6.5% at Day 3, 49.3±9.5% at Day 5 and
36.1±5.8% at Day7 (Figure 3.2 II). PDX1 positive nuclei were observed within
cells comprising the tubular complexes at Day 5 (Figure 3.2 (I); B; arrows; *).
Therefore, PDX1 is transiently expressed only in Mist1'A acini supporting the
interpretation that they undergo a de-differentiation to progenitor cells.
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Figure 3.2: PDX1 is transiently expressed in Mist1'A acinar cell
cultures. (I) IF for PDX1 expression was performed on sections
from M is ti"A (A-D) and WT (E-H) immediately upon culturing (DO),
or after 1, 5, or 9 days (D) in culture. PDX1 was observed in Mist1v'
cultures at early time points (B, C) but not at Day 9 (D). Conversely,
PDX1 accumulation was not observed in WT cultures (E-H), or at
Day 0 for Mist1'A (A) or WT (E) cultures. Some tubular complexes
(*)

were

positive

for

PDX1

expression.

Sections

were

counterstained with nuclear marker DAPI (blue). Scale bar = 30 pm
(n=3). (II) Quantification of PDX1 positive cells in WT and M is ti'
acini cultured for 11 days. PDX1 is transiently expressed from Day
1-7 in M ist1A, but not in WT cultures. Multiple fields of view were
photographed and the amount of PDX1+ nuclei per 100 DAPI nuclei
was counted. The percentage of PDX1

positive nuclei was

determined as a proportion of 100 DAPI stained nuclei present in
tubular complexes as well among individual cells. Error bars
represent mean ± standard error, n=3, (p<0.01).

I)

M i s t i 'DO

WT

Co-IF of CK20 and PDX1 was performed to determine if tubular complexes were
derived from acinar cells that had first de-differentiated into pancreatic progenitor
cells (Figure 3.3). At Day 5 and 7 CK20 was observed in the M is ti4' cultures.
Confocal microscopy at Days 5 and 7 revealed tubular complexes that stained for
both PDX1 and CK20 (Figure 3.3; C; arrows, *). At this time point PDX1
accumulation was decreasing and CK20 was expressed by these cells. However,
by Day 9, the tubular complexes were all CK20 positive and PDX1 negative
(Figure 3.3; D; arrows, *). Interestingly, individual cells expressing both PDX1 and
CK20 were not observed at any time point.

While PDX1 marks progenitor cells of the pancreas, PDX1 is also expressed in
adult pancreatic islets (Babu et al., 2008). Therefore, it is possible that these
PDX1+ cells are (3-cells. To address this possibility, both insulin and PDX1
expression was examined via co-IF. Co-labelling for PDX1 and insulin did not
show insulin accumulation in PDX1 positive cells, nor any insulin positive cells
anywhere and at any time point in the M is ti4 cultures (Figure 3.4; B-F). As a
positive control, co-expression of PDX1 and insulin was observed within islets of
WT pancreatic tissue as expected (Figure 3.4; A).

It is possible that the cells giving rise to CK20 positive cells represent a
progenitor cell population or a duct cell population that gradually takes over the
culture that is present only in M is ti4' cultures. If this were the case then we
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Figure 3.3: Individual tubular complexes contain both PDX1 and
CK20 positive cells. Co-IF for PDX1 (red) and CK20 (green)
expression on Mist1'A acini at Day (D) 3 (A), D5 (B), D7 (C), and D9
(D) in culture. Accumulation of PDX1 (white arrows) was observed
in tubular complexes (*) and at Day 7, CK20 (yellow arrows) and
PDX1 expression was observed within the same tubular complex
(C). Sections were counterstained with nuclear marker DAPI (blue).
Scale bar = 15 pm (n=3).

D5

D3
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Figure 3.4: The PDX1+ cells found in the MistTA cultures do not
express insulin. Co-IF for PDX1 (green) and insulin (red) expression
on WT pancreatic tissue (A) or Mist1'A acini cultured for up to 9
days. PDX1+ cells in the Mist1’A cultures (B-F) did not express
insulin. Sections were counterstained with nuclear marker DAPI
(blue). Scale bar = 30pm (n=3).
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would expect to see enhanced proliferation of this population within M is ti"A acinar
cultures to account for the increased presence of tubular complexes over time.
To assess proliferation, IF using an antibody against phospho-histone 3 (pH3), a
mitotic marker (Scott et al., 2005; Ribalta et al., 2004; Hendzel et al., 1998) was
performed at Days 1-11 for both WT and Mist1'A acinar cultures. This experiment
was repeated using Ki67, another proliferation marker (Scholzen and Gerdes,
2000). Less than 1% of cells for WT and MistTA cultures were observed to be
undergoing proliferation at any time point (Figure 3.5, A-B). Interestingly, Ki67 or
pH3 positive cells that were observed were not present within the tubular
complexes, suggesting that the difference observed between WT and Mist1'A
cells in culture was not due to enhanced proliferation within the tubular
complexes (Figure 3.5; C-D) and that the tubular complexes were not the result
of expansion of a non-acinar cell population.

TUNEL analysis was performed on WT and MistV/' cultures to assess the amount
of cell death that was occurring in these cultures, as tubular complex formation
may be a result of a block in apoptosis specific to the M istl^' cultures. Fewer
apoptotic cells were observed in M is ti'A cultures compared to WT (Figure 3.6, I;
A-F). Quantification of apoptotic cells over time (Figure 3.6 II) revealed WT acinar
cells contained more TUNEL positive cells at Day 9 (91.5±1.9% TUNEL+ cells)
and 11 (71.4±3.2% TUNEL+ cells) respectively. MistTA cultures had fewer
apoptotic cells: 38.9±11.04% (D9), 44.9±8.1% (D11).
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Figure 3.5: Limited proliferation is observed in both M is tiA and WT
cultures. IF for Ki67 on sections of WT and Mist1'A acini cultured for
9 days. Images represent the few proliferating cells that were
observed. No difference in the amount of proliferation was observed
between WT and MistT/_ cultures. Ki67 was not observed in any of
the tubular complexes in MistTA cultures (*; C-D), although a few
select nuclei away from the complexes did stain positive for Ki67 (B;
arrows), or can occasionally be observed in WT cultures (A; arrow).
Sections were counterstained with nuclear marker DAPI (blue).
Scale bar = 12 pm (n=3).
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The tubular complexes observed in M isti''A cultures contained very few TUNEL
positive nuclei (Figure 3.6, I; B) whereas tubular complexes were almost always
apoptotic in WT animals, indicating that the ability of MistTA to de-differentiate
may be due to an increased ability for M is ti_/" cells to survive in culture (Figure
3.6, I; C, F) and that the formation of tubular complexes alone do not account for
cell survival. Fifty tubular complexes in each condition were assayed and the
number of TUNEL positive cells within cysts was quantified. 68.6 ± 8.5% of cells
within tubular complexes were apoptotic in WT cultures at Days 5-11 in contrast
to 2.6 ± 2.5% of the cells in M is ti-/" cysts (p<0.01). Furthermore, 41.73 ± 1.7% of
M is ti'/_ cells found outside of tubular complexes at D5-11 were apoptotic
compared to only 2.6 ± 2.5% of cells present within M is ti_/" cysts (p<0.01). WT
clusters of all sizes and shapes contain apoptotic cells and cells not in clusters
appear to die more frequently, especially at later time points (Figure 3.6, I; D, E,
F).

3.2

P ancreatic acin ar cells tran s-d ifferen tiated into tu b u lar com plexes in

vitro and in vivo

The appearance of tubular complexes, limited proliferation and a change in the
expression of differentiation markers suggests acinar to duct cell trans
differentiation in M isti meultures. However, to definitively show that the originating
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Figure 3.6: WT cultures exhibit increased apoptosis compared to
MistTA cultures. (I) TUNEL analysis on M istT'' (A-C) and WT (D-F)
acini grown in culture for up to 11 days revealed apoptotic cells
(green; arrows). Cells not in clusters are almost always apoptotic.
Sections were counterstained with nuclear marker DAPI (blue).
Scale bar = 15pm (n=3). (II) The percentage of TUNEL positive
cells was determined as a proportion of 100 DAPI stained nuclei in
WT and M istT'' acini cultured over 11 days.

Error bars represent

mean ± standard error, n=3, p<0.01. (Ill) The number of TUNEL
positive cells was determined specifically within the cysts of M istT''
(28 cysts in total counted) and WT (9 cysts in total) cultures. The
percentage of TUNEL positive nuclei was determined as a
proportion of the number of TUNEL positive nuclei present divided
by the total number DAPI stained nuclei in all tubular complexes.
Error bars represent mean ± standard error, n=3, p<0.01. (IV) The
number of TUNEL positive cells was determined specifically within
the cysts of MistTA or within individual MistTA cell clusters at Days
5-11. Error bars represent mean ± standard error, n=3, p<0.01.

M is ti'/m
WT

INDIVIDUAL
CELLS

CYSTS

cells for the tubular complexes formed In Mist1'A cultures are acinar cells, lineage
tracing analysis was performed using genetically altered mice with the M isti
coding region replaced with a modified ere recombinase protein (Mist1+/CreERT)
crossed to mice that have a reporter locus in which LacZ expression is
irreversibly activated following creERT recombination at the ROSA26 locus
(ROSA26r; indicated as R26r). Therefore, the fate of cells could be examined in
the presence (Mist1+/CreERTR26r) or absence {Mist1CreERT/CreERTR26r) of MIST1.
To confirm the specificity of ere recombinase activity following tamoxifen
injection, pancreatic tissue was examined by X-gal histochemistry on cryostat
sections from mice sacrificed one week after the last injection of tamoxifen
(Figure 3.7). In the absence of tamoxifen no X-gal staining was observed (Figure
3.7, I; A). Following tamoxifen treatment, X-gal staining was observed in the
majority of acinar tissue (Figure 3.7, I; B-D) but was not observed in duct cells,
either in larger ducts or in small ducts entering into the acini (Figure 3.7, II;
arrows; and D; *). Surprisingly, a small population of islet cells were observed to
be X-gal positive (Figure 3.7, I; B and D), indicating a small percentage of cells
express MIST1 at low levels. Since IF analysis of the cultures showed no insulin
expression at any time point, it is likely that any X-gal expression observed in
culture would indicate acinar cell origin rather than an endocrine origin.

To determine if the cells within tubular complexes in vitro are derived from acinar
tissue, acinar cells from Mist1CreERT/CreERTR26r mice were isolated one week after
the final tamoxifen treatment, cultured, and assessed up to seven days by X-gal
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Figure 3.7: Tamoxifen induced recombination o f M isti CreERT/+R26r
pancreatic tissue. (I) X-gal histochemistry followed by H&E staining
on fresh, frozen sections of pancreatic tissue from Mist1CreERT/+R26r
mice without (A) or with (B-D) tamoxifen treatment. Recombination
based on |3-galactosidase expression was observed in acinar cells
and a subset of islet cells (arrowheads), but not in intercalated (C;
yellow arrows) or interlobular (D; *) ducts. I - Islets. Magnification
bar represents 60 pm, n=3 (II) Co-IF for amylase (acinar; red) and
(3-galactosidase (acinar; green) showed co-localization of amylase
and (3-galactosidase within acinar cells (G; white arrow head).
Sections were counterstained with nuclear marker DAPI (blue).
Scale bar = 60 pm (n=2).

S9

histochemistry (Figure 3.8). Mist1'A acinar cells were X-gal positive (Figure 3.8, AB) as were the cells that gave rise to the tubular complexes observed at Days 5
and 7 in cultures (Figure 3.8, C-D).

To confirm the specific conversion of acinar cells to duct or progenitor cells in
culture, co-IF for CK20 and (3-galactosidase (Figure 3.9; A-F) and PDX1 and (3galactosidase (Figure 3.9; G-L) was performed, respectively. The only way to
obtain (3-gal/CK20 positive cells would be through trans-differentiation. Initially
cells expressed (3-galactosidase, but not CK20, indicating that they were acinar in
origin (Figure 3.9; A-C). By Day 7 accumulation of both CK20 (Figure 3.9; E) and
(3-galactosidase (Figure 3.9; D) is observed within the same tubular complex
(Figure 3.9; F), indicating that acinar to duct cell trans-differentiation had
occurred. Furthermore, at Day 1, acinar cells expressed PDX1 (Figure 3.9; H) as
well as (3-galactosidase (Figure 3.9; G) indicating that the original acinar
population was de-differentiating (Figure 3.9; I) and became progenitor cells over
the first few days in culture. As cells trans-differentiated into duct cells by Day 7
they no longer showed PDX1 accumulation (Figure 3.9; K and L) but maintained
3-galactosidase (Figure 3.9; J and L) expression, again indicating that tubular
complexes originated from acinar cells.

To examine the origin of the tubular complexes observed in Mist1'A animals, in
vivo lineage tracing was performed followed by acute CIP experiments.
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Figure 3.8: Cells within tubular complexes are derived from acinar
tissue. X-gal histochemistry was performed on acinar cultures from
Mist1CreERT/CreERTR26r following Tamoxifen gavage (2 mg/mL - 4
times) up to 7 days after isolation. Tubular complexes (*) positive
for ß-galactosidase were observed at day 5 (C; D5) and day 7 (D;
D7). Scale bar = 20 pm (n=2).
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Acinar cells give rise to both CK20 and PDX1
j cells. Co-IF for P-galactosidase (green) and PDX1 (red)
jt

CK20 (red) (A-F) at Day 1 (D1; A-C; G-l) and Day 7 (D7; D-

J-L) after isolation. Co-localization of PDX1

(red) and P-

galactosidase (green) was seen at day 1 (G-l; arrows). CK20 (red)
and P-galactosidase (green) was observed within a tubular complex
at day 7 (*; F). Sections were counterstained with nuclear marker
DAPI (blue). Scale bar = 25pm (n=2).

Acinar cells give rise to both CK20 and PDX1
j cells. Co-IF for 0-galactosidase (green) and PDX1 (red)
jr CK20 (red) (A-F) at Day 1 (D1; A-C; G-l) and Day 7 (D7; DJ-L) after isolation. Co-localization of PDX1

(red) and 0-

galactosidase (green) was seen at day 1 (G-l; arrows). CK20 (red)
and 0-galactosidase (green) was observed within a tubular complex
at day 7 (*; F). Sections were counterstained with nuclear marker
DAPI (blue). Scale bar = 25pm (n=2).
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Pancreatic injury was induced by seven IP injections of caerulein to Mist1+/CreERT
R 2 6 r{n=3) and M is tiCreERT/CreERTR26r mice (n=3). Mice were sacrificed 24 h, 48
h and 7 days after initiating pancreatitis. Saline-injected control mice showed
normal acinar cell morphology for W T pancreatic tissue and disorganization of
M is ti'1' pancreatic tissue, but no apparent tubular complexes, as described
previously (Kowalik et. al., 2006). Histological analysis of cerulein injected mice
revealed that tubular complexes were X-gal positive, which indicated that they
originated from acinar tissue (Figure 3.10; A-B and D-E; arrows). By 7 days after
initiating pancreatitis, both Mist1CreERT/CreERT(Figure 3.10, C) and Mist1+/CreERT
(Figure 3.10, F) acinar tissue had regenerated and X-gal staining was once again
restricted to acinar tissue and not found in ductal tissue (Figure 3.10, C, F;
arrows).
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Figure 3.10: Caerulein induced pancreatic damage results in
tubular complexes derived from acinar tissue. X-gal histochemistry
on pancreatic tissue sections from Mist1CreERT/CreERTR26r (KO; A-C)
or Mist1CreERT/+R26r (HET; D-F) following tamoxifen gavage (2
mg/mL - 4 times) and 24 (A, D), 48 (B, E) and 168 (C, F) hours after
initiation of CIP. (3-galactosidase positive tubular complexes (red
arrows) were observed at 24 and 48 hours after initial CIP injection.
A large 3-galactosidase negative interlobular duct can be seen (E;
black arrow). Seven days after CIP, X-gal staining was observed
only in acinar tissue, not within ductal tissue (C, F; yellow arrows).
Sections were counterstained with H&E. Scale bar = 60 pm (n=3)
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C H A P T E R 4:

4.1

D IS C U S S IO N

C onclusions

1. M is ti'' acinar cells undergo trans-differentiation into duct cells when
cultured in collagen.
2. Trans-differentiation of M isti '' acinar cells involved the transient
appearance of a PDX1+ population of cells suggesting that these cells
assume a progenitor cell intermediary stage.
3. M is ti"/" tubular complexes exhibit decreased apoptosis compared to WT
acini. M is ti '' and WT cultures did not differ in cell proliferation.
4. Mist1'A acinar cells assume a tubular complex morphology following
cerulein induced pancreatitis injury.

4.2

G eneral discussion

Studies have shown trans-differentiation of mature acinar cells into duct and islet
cells in vitro (Sawey et al., 2007; Baeyens et al., 2005; Minami et al., 2005;
Sphyris et al., 2005; Song et al., 2004; Lardon et al., 2004; Zhu et al., 2004;
Rooman et al., 2000; Wagner et al., 1998). However, the intrinsic factors
regulating this process have yet to be defined. MIST1, an exocrine specific
transcription factor, is crucial for complete differentiation and maturation of acinar
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cells (Pin et al., 2001), that, when deleted, results in disorganization and
functional deficits in these cells (Luo et al., 2005; Johnson et al., 2004; Rukstalis
et al., 2003; Pin et al., 2001). For instance, Mist1'A mice exhibit premature
activation of digestive enzymes within acinar cells, autolysis and tissue damage
(Pin et al., 2001). However, Mist1'A mice do not exhibit gross morphological
defects (Pin et al., 2001). Therefore, MIST1 may be one regulator of acinar trans
differentiation.

Preliminary studies done in the Pin laboratory have revealed that the majority of
Mist1'A acini assume a tubular complex phenotype similar to what is observed in
acinar to duct cell trans-differentiation. Therefore, to determine whether these
tubular complexes represent acinar cells that have lost (de-differentiated), or
changed (trans-differentiated) their phenotypic characteristics, or whether these
tubular complexes are a result of other pancreatic lineages altogether, IF analysis
and lineage tracing analysis was conducted. In the absence of MIST1, primary
acinar cells, isolated and placed in a collagen matrix, rapidly lost their
differentiated phenotype and formed tubular complexes similar to the cysts
observed in vivo following induced pancreatic damage. In addition, there was
transient activation of PDX1, and decreased apoptotic cells in MistTA acini,
specifically within tubular complexes, suggesting these cysts had de
differentiated and had enhanced cell survival compared to WT cells in culture.
Furthermore, lineage tracing analysis in vitro confirmed that these tubular
complexes were composed of trans-differentiated acinar cells, which also
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express ductal markers, such as CK20. Lineage tracing in vivo following induction
of pancreatic injury showed acinar cells morphologically taking on a tubular
complex phenotype. These results suggest that MIST1 assists in stabilizing the
acinar cell phenotype.

4.3

Loss o f differentiatio n characteristics in W T and MistT/macinar cell
cultures

Both Mist1'Aand WT acinar cells exhibit an unstable differentiated phenotype
over time in culture such that by Day 5 amylase expression is dramatically
reduced in both groups(quantitative data not shown). Also at Day 5, MistVA
cultures began to express CK20 and form tubular complexes, which consisted of
a lumen surrounded by flattened cells. By Day 9, the tubular complexes only
stained positive for CK20. Furthermore, by Day 9 80-90% of MistV^ clusters
contained at least one tubular complex (data not shown). Together the altered
morphology as well as protein expression demonstrate that M istl^' cell phenotype
no longer display characteristics of mature acinar cells, namely amylase
expression and acini in clusters.

A loss of differentiation markers in WT and MistVA acinar cell cultures
has also been reported in previous studies (Shi et al., 2009). MistVA mice show a
significant increase in damage during pancreatic injury and delay in acinar cell
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recovery. Mist1'A mice demonstrate increased severity to acute and chronic
supramaximal secretagogue stimulation, one method of inducing pancreatic
injury (Kowalik et al., 2007). In addition, 12 month old untreated Mist1'A mice
exhibit an accumulation of these same tubular complexes, based on expression
of the duct cell marker cytokeratin-20 (CK20) (Pin et al., 2001). These findings
suggest that MIST1 may sustain the acinar cell phenotype as well as provide a
mechanism of protection against pancreatic injury (Kowalik et al., 2007).

Another major difference between MistTAand WT cultures is the expression
pattern of PDX1, which may also contribute to the observed instability in cell
phenotype. Mist1'A cultures displayed transient PDX1 expression, with a peak
seen at D3 and then steadily decreased for the remaining time points.
Interestingly, PDX1 staining was not observed in Mist1'A cells immediately after
culturing (DO), nor was it expressed in WT cells at any time point. PDX1 is
expressed in progenitor cells and primitive duct cells (Shiraki et al., 2008;
Deramaudt et al., 2006; Gu et al., 2002) and later restricted to (3-cells and 5-cells
in pancreatic development, but not seen within mature acinar cell populations
(Debas, 1997). This PDX1 expression pattern may indicate that Mist1'A acinar
cells have de-differentiated up the pancreatic developmental pathway to become
a progenitor cell population.
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By day 7, co-labelling of the MistT^ cultures showed tubular complexes
expressed both CK20/amylase and CK20/PDX1 demonstrating that tubular
complexes were switching from an acinar to a duct phenotype. Previous studies
have also found that PDX1 activation (Gymr et al., 2000; Rooman et al., 2000) or
transgenic expression of PDX1 (Miyatuska et al., 2006) was necessary for acinar
cells to become “duct-like” cells. P D X Iis required for the conversion of liver cells
to ‘pancreatic-like’ cells (Aviv et al., 2009; Yamada et al., 2006; Li et al., 2005;
Koizumi et al., 2004). Furthermore, over-expression of transcription factors Pdx1,
Mafa, and Ngn3 caused acinar to islet cell trans-differentiation in vivo (Zhou et
al., 2008) However, unlike the present study, lineage tracing was not performed.

4.4

O rigin o f tu b u la r com plexes

A number of possibilities exist for the origin of tubular complexes observed in the
Mist1'A cultures. Cultured primary acinar cells are likely to include some
contamination of non-exocrine cells during isolation, and therefore, one possibility
is that tubular complexes originate from expansion of one of these contaminating
cell types, or alternatively, a stem cell population. To address this issue, the
composition of the original cell population after culturing was analyzed using
immunofluorescence for acinar (amylase), endocrine (insulin) and duct cell
(CK20) markers. Abundant amylase staining was observed whereas fewer than
five percent of the original cell population (Day 0) stained positive for CK20, and
no insulin staining was observed at any time point. This finding suggests that the
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vast majority of the cultures were acinar in origin and that the contamination of
non-exocrine cell types was minimal.

Another possibility is that expansion of a stem cell population is responsible for
the tubular complexes formed (Gymr et al., 2000). To address the issue of a nonacinar proliferating contaminating cell type, staining for phospho Histone 3 (pH3)
and Ki67, two markers of proliferation respectively, was performed. Minimal
staining (less than 2% of cells) was observed for both pH3 and Ki67, indicating
that tubular complex formation cannot be a result of a subpopulation of
proliferating cells. However, tubular complex formation could be a result of
differential survival as MistTA cells had fewer TUNEL positive cells. For instance,
Reid and Walker (1999) found that acinar cells underwent apoptosis after
induction of pancreatitis, however, bcl-2 expressing cells were resistant to
apoptosis, and able to form tubular complexes. In the present study, Mist1';'
tubular complexes showed negligible TUNEL positive cells. Furthermore, the
Mist1'ATUNEL positive cells that were observed were primarily individual cells
that did not form tubular complexes. Together these observations suggest that
there may be signalling present in MistV^ tubular complexes which allows them to
assume an altered phenotype and become re-directed from apoptosis.

To definitively show that the originating cells for the tubular complexes formed in
M is ti'1 cultures are acinar cells, lineage-tracing analysis was performed.
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Molecular lineage tracing analysis in which the R26R LacZ gene was
permanently activated in mature acinar cells revealed acinar cells gave rise to
tubular complexes both in vitro following primary acinar cell culturing as well as in
vivo after induction of pancreatitis. The strength of this experiment is due to the
M is ti coding region being replaced with a modified protein, M is ti+/CreERTR26r
thereby allowing CreERT to be expressed wherever MIST1 is expressed, but
under untreated conditions, remain cytoplasmic and inactive. Another advantage
of this system is that it is Tamoxifen-inducible, allowing IJ-galactosidase to be
expressed in mature acinar cells and detected easily by IF/IHC assays over the
course of the experiment.

Acinar cells isolated from Mist1CreERT/CreERTR26r mice after tamoxifen treatment
formed tubular complexes that were X-gal positive indicating they originated from
the original population of isolated acinar cells. Furthermore, co-IF showed
accumulation of both (3-galactosidase and PDX1 at Day 1, indicative of acinar
cells de-differentiating to a progenitor cell population. At Day 7 accumulation of
both (3-galactosidase and CK20 was observed, suggesting that the tubular
complexes that formed were now duct cells, but had originated from the original
acinar cell population as well.

Previous studies have shown that Pdx1 down-regulation is necessary for
pancreatic progenitor cells to differentiate into duct cells. Wescott et al., (2009)
80

observed that although Pdx1 was not found in mature/differentiated pancreatic
duct cells, the initiation of branching morphogenesis required expression of Pdx1,
specifically at the junction where the tubule was developing. Wescott et al.,
(2009) observed PDX1 expressed during embryonic development in the ductal
epithelium and then down-regulated as pancreatic ducts mature. Similarly, in the
present study, PDX1 was observed initially during acinar cell de-differentiation,
but later in tubular complex formation, CK20 was expressed and PDX1 was not.
Interestingly, prior to day 5 in culture nuclear PDX1 expression was observed
with cytoplasmic localization of PDX1 observed at later time points which was
unexpected. However, cytoplasmic PDX1 location is reported and may be a
mechanism of rapid PDX1 down- regulation by nuclear export (Wescott et al.,
2009; Kawamori et al., 2003; Guillemain et al., 2004).

Lineage tracing analysis was also performed on Mist1CreERT/CreERTR26r mice to
determine the origins of the tubular complexes that arise after pancreatic injury.
After tamoxifen treatment Mist1CreERT/CreERTR26r received caerulein injections to
induce pancreatitis and the tubular complexes that formed were X-gal positive,
similar to what was observed in vitro. After CIP was terminated and mice were
given five or seven days to recover, only the acinar tissue was X-gal positive, but
the duct tissue was X-gal negative. This could indicate that trans-differentiated
tubular complexes reverted back to acinar cells. Future studies could quantify the
amount of X-gal positive acinar cells before CIP and compare it to the amount
observed following CIP or saline injections. After CIP, if the amount of X-gal
81

positive regenerated tissue is similar to saline controls it would support the
hypothesis that tubular complexes revert back to acinar tissue once the injurious
stimuli is eliminated. On the other hand, if the amount of X-gal positive tissue is
greatly reduced compared to saline injected animals, then it could be argued that
the regeneration arose from a non-labeled, possible non-acinar, cell type.

Alternatively, the acinar tissue which did not trans-differentiate during CIP could
have proliferated, regenerating the acinar tissue observed, while the tubular
complexes underwent apoptosis when the injurious stimulus was removed. A
study done by Pinho et al., (2011) showed that when acinar cells de-differentiate
into a pancreatic progenitor cell in response to a stressor, such as CIP, the cells
activate a senescence programme. Part of the senescence program activation
includes activation of Ras and ERK signalling and inhibition of proliferation (Pinho
et al., 2011 ). Future research should investigate how the acinar tissue could
regenerate during recovery from CIP. For instance, TUNEL analysis could be
performed to determine if the tubular complexes undergo apoptosis when the
injurious stimulus is removed. Likewise, western blot analysis for senescence
program markers outlined in Pinho et al., (2011) could be used to understand the
mechanisms and pathways controlling the recovery period.
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4.5

S ig nalling in A c in a r to D uct Trans-differentiatio n

In the present study, there may be additional signalling present in M istl^' cells
which allow them to go from a de-differentiated progenitor cell to a transdifferentiated duct cell. Previous experiments have shown that Epidermal growth
factor (EGF) signalling is important for trans-differentiation of acinar to duct or 13cells (Sawey et al., 2007; Means et al., 2005; Minami et at., 2005). Several
studies have added EGF or transforming growth factor a (TGFa) to culture
media, two EGF receptor activators, in order to cause trans-differentiation within
acinar cell cultures (Okuno et al., 2007; Sawey et al., 2007; Baeyens et al., 2005;
Lu et al., 2005; Means et al., 2005; Minami et al., 2005; Wagner et al., 1998).
One downstream mediator of EGF signalling is ERK1/2 (Dabrowski et al., 1997)
and Minami et al., (2005) showed that acinar to (3-cell trans-differentiation is
dependent on extracellular signal regulated kinases ERK1 and ERK2 (ERK1/2)
signalling. Furthermore, when Minami et al., (2005) inhibited ERK1/2 activity the
trans-differentiation of acinar to (3-cells was greatly reduced.

Previous work in the Pin lab suggests that ERK1/2 may be active in MistT/' acinar
cell cultures. Both WT and MistTA primary acinar cell cultures showed increased
phospho- and total ERK1/2 compared to WT and MistTAwhole pancreas,
however, this increase was much more pronounced in the MistTA acinar cells.
Furthermore, when ERK inhibitors PD98059 and U0126 were applied to culture
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media, M istl'^ cultures showed decreased tubular complex formation. Therefore,
MIST1 may play a role in preventing up-regulation of ERK1/2 signalling in acinar
cells by maintaining acinar cell phenotype. Mist1'A cultures are able to activate
ERK signalling, survive, and form tubular complexes. Therefore, future
experiments which allow ERK signalling to become activated in WT isolated
acinar cells could test whether ERK signalling is the deciding variable for tubular
complex formation. For instance, phorbol 12-myristate 13-acetate (Chen and
Tan, 1998), Cocaine and delta-9-tetrahydrocannabinol (THC) (Valjent et al.,
2004), EGF and TGFa (Okuno et al., 2007; Sawey et al., 2007; Baeyens et al.,
2005; Lu et al., 2005; Means et al., 2005; Minami et al., 2005; Wagner et al.,
1998) could be pharmacological methods of artificially activating ERK signalling
in WT cultures.

It was also observed that WT cultures also exhibit greater cell death compared to
their M is tiA counterparts. Therefore, future experiments could include antiapoptotic agents, such as IDN-6556 (Valentino et al., 2003) or Gefitinib (Sordella
et al., 2004), to isolated WT acinar cells to determine if allowing WT cultures to
survive longer in culture would be sufficient to allow tubular complex formation.

Protein Kinase C (PKC) proteins is also implicated as an upstream regulator of
ERK1/2 activity (Heidkamp et al., 2001) and activator of the MAPK pathway (Lee
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et al., 2002; Liao et al., 1997). PKC proteins are important for a variety of
biological processes such as gene regulation, actin cytoskeleton rearrangements,
and apoptosis as well as a key mediator of acinar cell exocytosis (Cosen-Binker
et al., 2007; Chenwei et al., 2004; Gutcher et al., 2003; Harnett and Biancani,
2003; Williams et al., 2002; Reyland et al., 2000; Reyland et al., 1999).
Additionally, PKCs are over-expressed and activated in pancreatic cancer which
involves activation of the MAP/ERK pathway (El-Rayes et al., 2008). Likewise,
experiments in the Pin lab showed that PKC inhibitors not only decreased tubular
complex formation in Mist1'A primary acinar cell cultures, but also showed
decreased PDX1 staining compared to Mist1'Acontrol cultures.

4.6

Future Directions

In the present study it remains inconclusive if the CK20+ cells, which comprised
the tubular complexes, arise from PDX1+ cells, or whether they have two distinct
cell origins. In this study, the appearance of PDX1 in Mist1'A cultures suggests
that tubular complex formation may require an intermediate de-differentiation step
for acinar to ductal trans-differentiation to occur. Evidence from previous studies
also suggests that PDX1+ cells give rise to CK20+ cells. For instance, Wescott et
al., (2009) argued reversion to a progenitor cell state may be a necessary pre
requisite to genetically support the initiation of branching morphogenesis for
pancreatic ductal network formation. Likewise, Deramaundt et al., (2006) found
that PDX1 down-regulation is required for normal ductal expression of cytokeratin
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K19 as ectopic PDX1 expression inhibited K19 reporter gene activity in primary
pancreatic ductal cells. PDX1 suppression though short interfering RNA (siRNA)
to PDX1 resulted in normal K19 expression (Deramaundt et al., 2006). From
these studies it appears that PDX1 must be down regulated before ductal
markers can be expressed. However, to definitively show that CK20+ cells arise
from PDX1+ cells lineage tracing should be performed. For instance, crossing the
Mist1v~R26r mice with Pdx1-cre mice could be one way to map the fate of mature
acinar cells. This would determine whether PDX1+ cells give rise to CK20
positive tubular complexes.

It is unclear whether the PDX1 expression observed in Mist1v~cultures is the
cause of acinar cell de-differentiation or just a result of this event. Previous
studies have observed acinar cells de-differentiate into an embryonic progenitor
like cell in vitro which also express PDX1. For instance, Pinho et al., (2011) found
that cultured acinar cells co-expressed PTF1a and PDX1, displayed an
embryonic-type PTF1 transcriptional complex, activated Notch signaling, as well
as expressed various pancreatic progenitor cell markers such as CpA1, Sox9 and
Hnf1 b. Pinho et al., (2011) argued together these findings demonstrate acinar
cells which have a de-differentiated phenotype characteristic of pancreatic
embryonic progenitors. Likewise, in the current study one progenitor cell marker
(PDX1) was observed and it was interpreted as an intermediate de-differentiation
event necessary for the eventual trans-differentiation step. However, future
studies should better characterize if acinar to duct trans-differentiation take on a
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progenitor cell Intermediate by characterizing other pancreatic progenitor cell
markers such as CpA1, Sox9 and Hnf1 b as done by Pinho et al., (2011).

In addition to performing lineage tracing, future studies should investigate the
mechanism behind trans-differentiation. It is important to understand how the loss
of M is ti results in cells which more readily take on a pancreatic progenitor cell
phenotype, initiating acinar-to-duct cell trans-differentiation. Currently, Gjb1,
Rab3d, Rab2b, and Atp2c2, have been identified as targets of MIST1 (Garside et
al., 2010; Tian et al., 2010; Johnson et al., 2004; Rukstalis et al., 2003) and all
are expressed in mature acinar cells. Likewise, MIST1 is a positive regulator of
connexin32 (Cx32) gene expression as M isti'A mice show a decrease in Cx32
and consequently, a disruption in intercellular communication pathways and
acinar gap junctions (Rukstalis et al., 2003). Furthermore, Mist1'/~mice exhibit
intracellular zymogen activation and possess molecular changes observed in
pancreatic injury such as increases in transcription factors (p8), secreted lectins
(Regl/PSP and PAP1/Reglll) and the cholecystokinin A receptors (CCK AR) (Pin
et al., 2001) as well as disruption in calcium handling (Luo et al., 2005). However,
although these factors are all linked to M isti, it remains unclear what their role is
with respect to trans-differentiation, or if they play a role at all. Therefore, future
research should aim to characterize and understand how the loss of M isti allows
for acinar cells to de-differentiate to a pancreatic progenitor cell phenotype as the
initial step in acinar-to-duct trans-differentiation.
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Likewise, future research should elucidate the mechanism responsible for PDX1 +
progenitor cells becoming CK20+ cells. For example, PDX1 and myeloid
ecotropic viral insertion site 1a (M EISIa) and pre-B-cell leukemia transcription
factor 1b (PBX1b), two members of the TALE homeodomain factor family,
regulate K19 gene transcription through a 16-bp c/s-regulatory element located
between -341 and -325 upstream of the transcription start site of the K19 gene
(von Burstin et al., 2010; Deramaundt et al., 2006). All cells of the endocrine and
exocrine pancreas are derived from PDX1+ progenitor cells throughout
embryogenesis (Gu et al., 2002) and PDX1 is the earliest transcription factor
which can give rise to all three pancreatic cell lineages (Shiraki et al., 2008).
Therefore, it is likely that PDX1 occupies the K19 promoter during acinar to duct
trans-differentiation in vitro by re-capitulating early pancreatic developmental
pathways. However, it is unclear as to why de-differentiated PDX1+ cells
continue to trans-differentiate into duct cells, rather than remain in a progenitor
state, or re-differentiate into acinar cells. This is something that is currently
unknown.

Furthermore, future research should elucidate the cell types that M istl^' acinar
cells go through in order to reach a progenitor cell type intermediate. One of the
first exocrine specific transcription factors is Hairy and Enhancer of Splitl
(HES1), which acts as a negative regulator of endocrine differentiation by
inhibiting Ngn3 expression and is controlled by Notch signalling (Jensen et al.,
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2000). Later in embryogenesis, exocrine-restricted progenitors are marked by
HES1 and Notch activation and these cells can later differentiate into duct cells
(Kopinke et al., 2010). Previous studies have also showed the progenitor markers
ubiquitin carboxyl-terminal esterase L1 (UchM), PDX1 and Epiplakinl expressed
in centroacinar cells (Yoshida et al., 2008; Hosotani et al., 2004; Suzuki et al.,
2003; Yokoyama-Hayashi et al., 2002). Centroacinar cells and terminal duct cells
lie at the border of peripheral acinar/adjacent ductal epithelium and are one cell
type thought to be exocrine specific pancreatic progenitors (Rovira et al., 2010).

Another transcription factor, PTF1a, is found in pancreatic progenitor cells and
activated immediately following PDX1 expression in development (Habeneret al.,
2005; Krapp et al., 1996). PTF1a is also found in mature acinar cells and plays a
role in acinar cell maturation and differentiation by regulating the expression of
acinar cell differentiation markers (Habener et al., 2005; Krapp et al., 1996).
Therefore, M is tr/_acinar cells should express HES1 and PTF1a at some time
during Days 1-5 in vitro if they are reverting up the pancreatic developmental tree
during their initial de-differentiation event. Therefore, future experiments should
aim to temporally characterize some of the cell markers of the intermediate cell
types that pancreatic progenitor cells go through to become mature acinar cells
during development, such as Hes1 and PTF1a, in addition to PDX1. This will lead
to a better understanding of the process acinar cells undergo in order to achieve
a pancreatic progenitor cell phenotype, before ultimately trans-differentiating into
duct cells.
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An alternate explanation is that acinar cells de-differentiated further up the
pancreatic developmental pathway further than progenitor cells to
undifferentiated endoderm. One way to determine if the observed progenitor cells
continue to de-differentiate to non-pancreatic cells is to look at PDX1 expression
in vitro together with homeobox gene HLXB9, a marker of specified endoderm
which proceeds PDX1 in pancreatic development. If acinar cells have de
differentiated up the pancreatic developmental pathway past progenitor cells to
endoderm, PDX1 negative, HLXB9 positive cells should be observed over Days
1-7 in culture.

In conclusion, one of the strengths of the present study was that it was shown,
through lineage tracing analysis, that the originating cells for the tubular
complexes formed in M is tiA cultures are acinar cells. However, the mechanisms
and the intermediate cell types in which Mist1'A acinar cells undergo to achieve
this trans-differentiation remain inconclusive, and thus is the area future research
should target. This is important to better understand the contribution of acinar-toduct trans-differentiation to invasive pancreatic cancer, which remains unknown.
Both human and mouse models of pancreatic disease have demonstrated a link
between acinar cell de-differentiation and pancreatic disease (Houbracken et al.,
2010; Zhu et al., 2007). Furthermore, in Pancreatic ductal adenocarcinoma and in
carcinomas of stomach epithelium, absence of MIST1 expression has been
identified (Lennerz et al., 2010; Shi et al., 2009).
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The broader significance of this project is that cell plasticity can be one
mechanism for repair and regeneration essential for wound healing and tissue re
modeling (Carlson, 2005). Furthermore, cell plasticity may act as a general
protective mechanism (Carlson, 2005). In many organs systems, chronic stress
or injury resulted in regeneration of normal tissue, as well as metaplasia, which
occurred through selective proliferation, differentiation of stem cells, or trans
differentiation (Tosh and Slack, 2002). For instance, lineage tracing was used to
show that de-differentiation of differentiated cells (Rawlins et al., 2009) and renal
tubular epithelium (Humphreys et al., 2008) was used in normal growth and
repair after tissue injury.
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